EMBL -EBI: Virtual Event, Tuesday 10th November 2020

Background & Motivation
• Digital Endpoints/Biomarkers based on mobile devices and sensor technology are currently
being investigated in many clinical studies
• Data collected from sensors is entirely different from any other clinical data collected
• No agreement or guidance on how to best process and analyse sensor data exists
• First guidance proposals on how to develop digital endpoints/biomarkers for clinical studies
only just appearing

Scope
• Overview on current strategies to develop digital endpoints/biomarkers
• Overview on current practices in collecting, processing and analyzing digital biomarker data
• Use cases from both academia and industry
• Analysis related issues like statistical methods for high-dimensional time series data;
addressing data types like touch and voice; relationship to disease and established clinical
outcomes
• Data related issues like missing data, gathering, transferring, anonymizing, sharing

Anticipated workshop outcomes
• Shared understanding on current practices for digital biomarker data analysis in clinical
studies
• Understanding current gaps and future steps of digital biomarker data analysis

Click here for information and registration

Content courtesy of EMBL -EBI

Related Post

  • Posted on 15 September, 2021
    Redenlab are presenting some of their work on Parkinson’s Disease and speech at the upcoming virtual Movement Disorders Society Conference...
    • Posted on 14 September, 2021
      Over the past two decades, genomic studies have played an increasingly important role in exploring the history of our own...
      • Posted on 31 May, 2021
        Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or...